Prachi Kothari
Memorial Sloan Kettering Cancer Center
7 Papers
2 Citations
Prachi Kothari is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Medicine & Retinoblastoma. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.
P. Pallavi Madhusoodhan,Joanna Pierro,Jordan Musante,Prachi Kothari,Bradley Gampel,Burton Appel,Adam S. Levy,Adit Tal,Laura Hogan,Archana Sharma,Shari Feinberg,Alissa Kahn,Ashley Pinchinat,Teena Bhatla,Chana L. Glasser,Prakash Satwani,Elizabeth A. Raetz,Kenan Onel,William L. Carroll +18 more
TL;DR: The characteristics of coronavirus disease 2019 (COVID‐19) in this population and also its impact on pediatric cancer care in the New York region during the peak of the pandemic are described.
123
The value of cell-free DNA for molecular pathology.
Caitlin Stewart,Prachi Kothari,Florent Mouliere,Richard Mair,Saira Somnay,Ryma Benayed,Ahmet Zehir,Britta Weigelt,Sarah-Jane Dawson,Sarah-Jane Dawson,Maria E. Arcila,Michael F. Berger,Dana W.Y. Tsui +12 more
TL;DR: The advantages of cell‐free nucleic acids as analytes in different body fluids, including blood plasma, urine, and cerebrospinal fluid, and their clinical applications in solid tumours and haematological malignancies are discussed.
121
Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience
Prachi Kothari,Francesco Marass,Francesco Marass,Julie L. Yang,Caitlin Stewart,Dennis Stephens,Juber Patel,Maysun Hasan,Xiaohong Jing,Fanli Meng,Jeanette Enriquez,Kety Huberman,Agnes Viale,Jasmine H. Francis,Jasmine H. Francis,Michael F. Berger,Michael F. Berger,Neerav Shukla,David H. Abramson,David H. Abramson,Ira J. Dunkel,Ira J. Dunkel,Dana W.Y. Tsui,Dana W.Y. Tsui +23 more
TL;DR: Whether sufficient tumorderived cfDNA is shed in plasma from retinoblastoma tumors to enable noninvasive RB1 mutation detection is analyzed.
43
Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
David H. Abramson,David H. Abramson,Diana Mandelker,Jasmine H. Francis,Jasmine H. Francis,Ira J. Dunkel,Ira J. Dunkel,A. Rose Brannon,Ryma Benayed,Michael F. Berger,Maria E. Arcila,Marc Ladanyi,Danielle Novetsky Friedman,Gowtham Jayakumaran,Monica Diosdado,Melissa A. Robbins,Dianna Haggag-Lindgren,Neerav Shukla,Michael Walsh,Prachi Kothari,Dana W.Y. Tsui,Dana W.Y. Tsui +21 more
- 01 Mar 2021
TL;DR: In this paper, the authors performed a cross-sectional study of the association of circulating tumor DNA (ctDNA) from retinoblastoma and simulating lesions with disease course.
20
Mutant-RB1 circulating tumor DNA in the blood of unilateral retinoblastoma patients: What happens during enucleation surgery: A pilot study
David H. Abramson,Diana Mandelker,A. Rose Brannon,Ira J. Dunkel,Ryma Benayed,Michael F. Berger,Maria E. Arcila,Marc Ladanyi,Danielle Novetsky Friedman,Gowtham Jayakumaran,Monica S. Diosdado,Melissa A. Robbins,Dianna Haggag-Lindgren,Neerav Shukla,Michael Walsh,Prachi Kothari,Dana W.Y. Tsui,Jasmine H. Francis +17 more
TL;DR: In this article , the authors found that after transection of the optic nerve, RB1 VAF was measurably lower than pre-enucleation levels within five minutes, 50% less within 15 minutes and 90% less by 40 minutes.